Borgia G - Search Results

1

Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A.

Gentile I, Borgia F, Coppola N, Buonomo AR, Castaldo G, Borgia G. Gentile I, et al. Among authors: borgia g, borgia f. Curr Med Chem. 2014;21(12):1391-404. doi: 10.2174/0929867321666131228222215. Curr Med Chem. 2014. PMID: 24372205 Review.

2

The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.

Gentile I, Carleo MA, Borgia F, Castaldo G, Borgia G. Gentile I, et al. Among authors: borgia g, borgia f. Expert Opin Investig Drugs. 2010 Jan;19(1):151-9. doi: 10.1517/13543780903501505. Expert Opin Investig Drugs. 2010. PMID: 20001560 Review.

3

Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era.

Gentile I, Borgia F, Zappulo E, Buonomo AR, Spera AM, Castaldo G, Borgia G. Gentile I, et al. Among authors: borgia g, borgia f. Rev Recent Clin Trials. 2014;9(1):1-7. doi: 10.2174/1574887108666131213120354. Rev Recent Clin Trials. 2014. PMID: 23859195 Review.

4

Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection.

Gentile I, Buonomo AR, Borgia F, Castaldo G, Borgia G. Gentile I, et al. Among authors: borgia g, borgia f. Expert Opin Investig Drugs. 2014 Apr;23(4):561-71. doi: 10.1517/13543784.2014.892581. Epub 2014 Mar 4. Expert Opin Investig Drugs. 2014. PMID: 24593285 Review.

5

MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection.

Gentile I, Buonomo AR, Borgia F, Zappulo E, Castaldo G, Borgia G. Gentile I, et al. Among authors: borgia g, borgia f. Expert Opin Investig Drugs. 2014 May;23(5):719-28. doi: 10.1517/13543784.2014.902049. Epub 2014 Mar 26. Expert Opin Investig Drugs. 2014. PMID: 24666106 Review.

6

Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.

Gentile I, Zappulo E, Buonomo AR, Borgia G. Gentile I, et al. Among authors: borgia g. Expert Rev Anti Infect Ther. 2014 Jul;12(7):775-82. doi: 10.1586/14787210.2014.920254. Epub 2014 May 20. Expert Rev Anti Infect Ther. 2014. PMID: 24840817 Review.

7

Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.

Gentile I, Coppola N, Buonomo AR, Zappulo E, Borgia G. Gentile I, et al. Among authors: borgia g. Expert Opin Investig Drugs. 2014 Sep;23(9):1211-23. doi: 10.1517/13543784.2014.921680. Epub 2014 May 21. Expert Opin Investig Drugs. 2014. PMID: 24848437 Review.

8

Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection.

Gentile I, Buonomo AR, Borgia G. Gentile I, et al. Among authors: borgia g. Rev Recent Clin Trials. 2014;9(2):115-23. doi: 10.2174/1574887109666140529222602. Rev Recent Clin Trials. 2014. PMID: 24882169 Review.

9

Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?

Gentile I, Buonomo AR, Zappulo E, Borgia G. Gentile I, et al. Among authors: borgia g. Expert Rev Anti Infect Ther. 2014 Jul;12(7):763-73. doi: 10.1586/14787210.2014.929497. Expert Rev Anti Infect Ther. 2014. PMID: 24918116 Review.

10

ABT-450: a novel protease inhibitor for the treatment of hepatitis C virus infection.

Gentile I, Borgia F, Buonomo AR, Zappulo E, Castaldo G, Borgia G. Gentile I, et al. Among authors: borgia g, borgia f. Curr Med Chem. 2014;21(28):3261-70. doi: 10.2174/0929867321666140706125950. Curr Med Chem. 2014. PMID: 25005190 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters